ANI Pharmaceuticals Inc (ANIP) — Strategic Asset Allocation Index
ANI Pharmaceuticals Inc (ANIP) has a Strategic Asset Allocation Index of 10.2% as of June 2023. Strategic assets (PP&E of $44.37 Million plus long-term investments of $-) total $44.37 Million, measured against net assets of $434.47 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ANI Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
ANI Pharmaceuticals Inc Strategic Asset Allocation Index (2011–2022)
This chart shows how ANI Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 10.2%, representing strategic assets of $44.37 Million against net assets of $434.47 Million USD. For live market cap and overall valuation, see ANI Pharmaceuticals Inc market capitalisation.
Annual Strategic Asset Allocation Index for ANI Pharmaceuticals Inc (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ANI Pharmaceuticals Inc from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ANI Pharmaceuticals Inc (ANIP) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 12.8% | $43.25 Million | $43.25 Million | $- | $338.54 Million | ▼ -1.9 pp |
| 2021 | 14.7% | $52.67 Million | $52.67 Million | $- | $358.74 Million | ▼ -6.4 pp |
| 2020 | 21.1% | $41.27 Million | $41.27 Million | $- | $195.70 Million | ▲ +2.0 pp |
| 2019 | 19.1% | $40.55 Million | $40.55 Million | $- | $212.79 Million | ▼ -0.3 pp |
| 2018 | 19.3% | $38.09 Million | $38.09 Million | $- | $197.26 Million | ▲ +7.6 pp |
| 2017 | 11.7% | $20.40 Million | $20.40 Million | $- | $174.76 Million | ▲ +5.2 pp |
| 2016 | 6.5% | $11.00 Million | $11.00 Million | $- | $169.65 Million | ▲ +2.0 pp |
| 2015 | 4.5% | $7.13 Million | $7.13 Million | $- | $160.08 Million | ▲ +0.7 pp |
| 2014 | 3.7% | $5.22 Million | $5.22 Million | $- | $139.78 Million | ▼ -7.3 pp |
| 2013 | 11.1% | $4.54 Million | $4.54 Million | $- | $40.96 Million | ▼ -1.6 pp |
| 2012 | 12.7% | $3.58 Million | $166.39K | $3.41 Million | $28.18 Million | ▲ +1.4 pp |
| 2011 | 11.3% | $4.27 Million | $861.36K | $3.41 Million | $37.82 Million | — |